The global recombinant DNA technology market is expected to reach USD 844.6 billion by 2025, according to a new report by Grand View Research, Inc. Success of genetically engineered human insulin in diabetes treatment has triggered the development of many other recombinant therapeutics and drugs. This has translated to the huge success of Recombinant DNA (rDNA) technology. This technology has offered significant prospects for elucidating the gap between disease and its effective treatment.
Widespread successful application of this technique in veterinary product development, genetically modified crop development, bio pesticides & biofuel production, and gene therapy, are expected to spur the adoption of this technology throughout the forecast period.
Use of Genetically Modified (GM) products, such as GM animals, developed using rDNA method are found to be indispensable to accelerate medical research. Furthermore, more than 3000 scientific studies have been carried out to assess the GM products safety in context to its impact on human health and environment.
In addition, there is rising need to improve the recombinant proteins’ production capacity by several folds, owing to increase in demand for effective therapeutics for disease treatment. The aforementioned fact pronounces the technological advances in this sector thus driving growth.
As per Monsanto and other proponents of GM crops, genetic engineering is one of the fastest and widely adopted agricultural innovations over the past few years. This, in turn, is expected bolster the adoption of rDNA technology for non-traditional applications.
Request a sample Copy of the Recombinant DNA Technology Market Research Report @ https://www.grandviewresearch.com/industry-analysis/recombinant-dna-technology-market/request/rs1
Key Takeways Of The Report :
Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/1399/ibb
Grand View Research has segmented the global recombinant DNA technology market on the basis of product, component, application, end-use, and region:
Recombinant DNA Technology Product Outlook (Revenue, USD Million, 2014 – 2025)
Recombinant DNA Technology Component Outlook (Revenue, USD Million, 2014 – 2025)
Recombinant DNA Technology Application Outlook (Revenue, USD Million, 2014 – 2025)
Recombinant DNA Technology End-use Outlook (Revenue, USD Million, 2014 – 2025)
Recombinant DNA Technology Regional Outlook (Revenue, USD Million, 2014 – 2025)
Browse Related Reports:
Oncology based Molecular Diagnostics Market : https://www.grandviewresearch.com/industry-analysis/oncology-based-molecular-diagnostics-market
Genomics In Cancer Care Market : https://www.grandviewresearch.com/industry-analysis/genomics-in-cancer-care-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: www.grandviewresearch.com/industry-analysis/recombinant-dna-technology-market